Le Hoang Mai, Mrejen Sarah, Sibilia Lise, Cohen Salomon Y
Department of Ophthalmology, Intercity Hospital, University Paris Est Créteil, Créteil, France.
Ophthalmic Center for Imagery and Laser, Paris, France.
Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2483-2490. doi: 10.1007/s00417-022-05637-2. Epub 2022 Mar 29.
To quantitatively analyze characteristics of choriocapillaris flow using spectral domain optical coherence tomography angiography (SD-OCTA) in eyes with chronic central serous chorioretinopathy (CSC) before and after treatment by photodynamic therapy (PDT).
Retrospective interventional study. Macular 3X3 SD-OCT scans were analyzed in eyes diagnosed with chronic CSC before and after treatment with half-fluence PDT. The choriocapillaris en face slabs were extracted from the SD-OCTA device after manual segmentation. En face choriocapillaris flow images were compensated with en face choriocapillaris structure images. Phansalkar local thresholding method was then used with a radius of 4 and 8 pixels. Percentage of flow deficits (FD%), number, size, and total area of FDs were computed for comparison, before and after treatment by half-fluence PDT.
Mean choriocapillaris FD% before PDT was of 58.36 + / - 11.88 and of 60.82 + / - 11.08 after PDT using radius 4 pixels with no significant difference (p = 0.140). Mean choriocapillaris FD% was of 58.63 + / - 11.08 before PDT and of 60.87 + / - 10.36 after PDT using radius 8 pixels with no significant difference (p = 0.200). Similarly, no significative difference was found in number, size, and total area of FDs, before and after half-fluence PDT, using radius 4 and 8 pixels in patients with chronic CSC.
Using Phansalkar local thresholding method, quantitative analysis of choriocapillaris with SD-OCTA found no significant change in choriocapillaris flow deficits before and after successful half-fluence PDT in patients with chronic CSC. Therefore, it seems that half-fluence PDT may not alter choriocapillaris perfusion, at least on a relative short-term basis.
使用光谱域光学相干断层扫描血管造影(SD-OCTA)定量分析慢性中心性浆液性脉络膜视网膜病变(CSC)患者在光动力疗法(PDT)治疗前后脉络膜毛细血管血流的特征。
回顾性干预研究。对诊断为慢性CSC的患者在半剂量PDT治疗前后进行黄斑区3×3 SD-OCT扫描分析。手动分割后从SD-OCTA设备中提取脉络膜毛细血管的正面平板图像。用脉络膜毛细血管结构图像对正面脉络膜毛细血管血流图像进行补偿。然后使用半径为4像素和8像素的Phansalkar局部阈值法。计算半剂量PDT治疗前后血流缺失百分比(FD%)、血流缺失的数量、大小和总面积以进行比较。
使用4像素半径时,PDT治疗前脉络膜毛细血管平均FD%为58.36±11.88,治疗后为60.82±11.08,无显著差异(p = 0.140)。使用8像素半径时,PDT治疗前脉络膜毛细血管平均FD%为58.63±11.08,治疗后为60.87±10.36,无显著差异(p = 0.200)。同样,在慢性CSC患者中,使用4像素和8像素半径时,半剂量PDT治疗前后血流缺失的数量、大小和总面积均无显著差异。
使用Phansalkar局部阈值法,通过SD-OCTA对脉络膜毛细血管进行定量分析发现,慢性CSC患者在成功进行半剂量PDT治疗前后,脉络膜毛细血管血流缺失无显著变化。因此,至少在相对短期的基础上,半剂量PDT似乎不会改变脉络膜毛细血管灌注。